Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.51 USD | +0.79% | +1.43% | -25.01% |
04-15 | Goldman Sachs Cuts Veracyte Price Target to $28 From $32, Maintains Buy Rating | MT |
02-26 | Morgan Stanley Trims Veracyte's Price Target to $21 From $22, Keeps Underweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.01% | 1.56B | |
-16.09% | 11.41B | |
+74.18% | 3.81B | |
-29.06% | 2.3B | |
-14.31% | 2.16B | |
+36.49% | 1.19B | |
-2.40% | 760M | |
-19.08% | 506M | |
-37.86% | 444M | |
+13.72% | 339M |
- Stock Market
- Equities
- VCYT Stock
- News Veracyte, Inc.
- Veracyte : SVB Leerink Adjusts Price Target on Veracyte to $60 From $55, Maintains Outperform Rating